Unison Advisors’s Biogen BIIB Stock Holding History

Unison Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Hold	5,078	–	–	0.08%	99
2026 Q1	$931K	Hold	5,078	–	–	0.07%	111
2025 Q4	$894K	Hold	5,078	–	–	0.08%	101
2025 Q3	$711K	Sell	5,078 -249	-5%	-$33.7K	0.06%	129
2025 Q2	$669K	Hold	5,327	–	–	0.07%	132
2025 Q1	$729K	Buy	5,327 +249	+5%	+$35.6K	0.09%	116
2024 Q4	$777K	Hold	5,078	–	–	0.09%	113
2024 Q3	$984K	Hold	5,078	–	–	0.12%	87
2024 Q2	$1.18M	Hold	5,078	–	–	0.15%	77
2024 Q1	$1.09M	Hold	5,078	–	–	0.11%	84
2023 Q4	$1.31M	Hold	5,078	–	–	0.14%	75
2023 Q3	$1.31M	Hold	5,078	–	–	0.15%	70
2023 Q2	$1.45M	Hold	5,078	–	–	0.16%	70
2023 Q1	$1.41M	Hold	5,078	–	–	0.16%	70
2022 Q4	$1.41M	Hold	5,078	–	–	0.18%	74
2022 Q3	$1.35M	Hold	5,078	–	–	0.25%	68
2022 Q2	$1.04M	Hold	5,078	–	–	0.27%	72
2022 Q1	$1.07M	Hold	5,078	–	–	0.26%	73
2021 Q4	$1.22M	Hold	5,078	–	–	0.29%	69
2021 Q3	$1.44M	Sell	5,078 -1,350	-21%	-$442K	0.36%	64
2021 Q2	$2.23M	Buy	6,428 +527	+9%	+$160K	0.41%	57
2021 Q1	$1.65M	Hold	5,901	–	–	0.32%	66
2020 Q4	$1.45M	Hold	5,901	–	–	0.33%	67
2020 Q3	$1.67M	Hold	5,901	–	–	0.48%	55
2020 Q2	$1.58M	Buy	5,901 +177	+3%	+$53.2K	0.53%	62
2020 Q1	$1.81M	Buy	+5,724	New	+$1.74M	1.95%	4

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Unison Advisors's BIIB Position: Q2 2026 in Review

Unison Advisors held its Biogen (BIIB) position steady in Q2 2026 at 5,078 shares worth $1.1M. The position accounts for 0.08% of the portfolio, ranked #99.

Unison Advisors first reported a position in BIIB in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.23M in Q2 2021. 269 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Unison Advisors held 5,078 shares of Biogen worth $1.1M as of Q2 2026.
Unison Advisors left its Biogen share count unchanged in Q2 2026.
Biogen made up 0.08% of Unison Advisors's portfolio in Q2 2026, its #99 holding.
Unison Advisors first reported a position in Biogen in Q1 2020 and has held it in 26 quarters since.
Unison Advisors's Biogen position peaked at $2.23M in Q2 2021.
269 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Unison Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.